• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冈田酸在药物预处理小鼠中诱导马洛里小体形成的机制。

Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.

作者信息

Yuan Q X, Nagao Y, Gaal K, Hu B, French S W

机构信息

Harbor-UCLA Medical Center, Torrance, California 90509, USA.

出版信息

Exp Mol Pathol. 1998 Oct;65(2):87-103. doi: 10.1006/exmp.1998.2231.

DOI:10.1006/exmp.1998.2231
PMID:9828150
Abstract

Drug-primed mice form Mallory bodies in their liver after various types of liver injury such as heat shock, drug refeeding, or ethanol ingestion. However, the mechanisms involved that lead to Mallory body formation after these different treatments are unknown. There may be a common pathway of Mallory body formation that is initiated by these different types of injuries. Recently it was shown that the phosphatase 1/2A inhibitor okadaic acid induced Mallory body formation, suggesting that the mechanism of formation involves hyperphosphorylation or oxidative stress-induced NFkappaB activation. To test this hypothesis we exposed drug-primed mice to okadaic acid and measured phosphorylation of Mallory body proteins immunohistochemically and by immunoblot chemiluminescence using an antibody specific for phosphothreonine. NFkappaB activation was measured by a gel shift retardation assay of nuclear lysates. Beginning 15 min after okadaic acid injection, complex changes were progressively seen in the liver cells focally including aggregation of cytokeratins 8 and 18 in hepatocytes which otherwise failed to stain normally with cytokeratin antibody. The aggregates stained positive with ubiquitin and phosphothreonine antibodies. Immunoblots showed a progressive increase in positive staining of the Mallory body band with the antibody to phosphothreonine. NFkappaB activation was progressive up to 2 h after okadaic acid treatment but was downregulated 7 days later. In summary we show for the first time the effect of okadaic acid on the liver cytokeratins in vivo. We conclude that hyperphosphorylation and NFkappaB activation may play a role in the early phases of Mallory body formation.

摘要

药物预处理的小鼠在经历各种类型的肝损伤(如热休克、重新给予药物或摄入乙醇)后,肝脏中会形成马洛里小体。然而,这些不同处理后导致马洛里小体形成的相关机制尚不清楚。可能存在一条由这些不同类型损伤引发的马洛里小体形成的共同途径。最近有研究表明,磷酸酶1/2A抑制剂冈田酸可诱导马洛里小体形成,这表明其形成机制涉及过度磷酸化或氧化应激诱导的核因子κB激活。为了验证这一假设,我们将药物预处理的小鼠暴露于冈田酸中,并通过免疫组织化学以及使用针对磷酸苏氨酸的特异性抗体进行免疫印迹化学发光法来检测马洛里小体蛋白的磷酸化情况。通过对核裂解物进行凝胶迁移阻滞试验来检测核因子κB的激活情况。在注射冈田酸后15分钟开始,在肝细胞中逐渐观察到复杂的变化,包括细胞角蛋白8和18在肝细胞中的聚集,而这些肝细胞原本不能被细胞角蛋白抗体正常染色。这些聚集体用泛素和磷酸苏氨酸抗体染色呈阳性。免疫印迹显示,马洛里小体条带与磷酸苏氨酸抗体的阳性染色呈逐渐增加趋势。在冈田酸处理后2小时内,核因子κB的激活呈逐渐上升趋势,但在7天后下调。总之,我们首次展示了冈田酸在体内对肝脏细胞角蛋白的影响。我们得出结论,过度磷酸化和核因子κB激活可能在马洛里小体形成的早期阶段起作用。

相似文献

1
Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.冈田酸在药物预处理小鼠中诱导马洛里小体形成的机制。
Exp Mol Pathol. 1998 Oct;65(2):87-103. doi: 10.1006/exmp.1998.2231.
2
Dexamethasone enhances mallory body formation in drug-primed mouse liver.地塞米松可增强药物预处理小鼠肝脏中马洛里小体的形成。
Exp Mol Pathol. 2000 Dec;69(3):202-10. doi: 10.1006/exmp.2000.2320.
3
Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.在体外,p38抑制剂可阻止马洛里小体(细胞角蛋白聚集体)的形成。
Exp Mol Pathol. 2006 Jun;80(3):228-40. doi: 10.1016/j.yexmp.2006.01.003. Epub 2006 Mar 23.
4
Mallory body formation by ethanol feeding in drug-primed mice.在药物预处理的小鼠中通过乙醇喂养诱导马洛里小体形成。
Hepatology. 1998 Jan;27(1):116-22. doi: 10.1002/hep.510270119.
5
Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin.
Exp Mol Pathol. 2001 Dec;71(3):241-6. doi: 10.1006/exmp.2001.2401.
6
The Mallory body as an aggresome: in vitro studies.作为一种聚集体的马洛里小体:体外研究
Exp Mol Pathol. 2002 Feb;72(1):17-23. doi: 10.1006/exmp.2001.2413.
7
Mallory body induction in drug-primed mouse liver.药物预处理小鼠肝脏中马洛里小体的诱导
Hepatology. 1996 Sep;24(3):603-12. doi: 10.1002/hep.510240324.
8
Heat shock in vivo induces Mallory body formation in drug primed mouse liver.体内热休克诱导药物预处理小鼠肝脏中马洛里小体的形成。
Exp Mol Pathol. 1995 Aug;63(1):63-76. doi: 10.1006/exmp.1995.1031.
9
The p105/50 NF-kappaB pathway is essential for Mallory body formation.p105/50核因子-κB信号通路对于马洛里小体的形成至关重要。
Exp Mol Pathol. 2005 Jun;78(3):198-206. doi: 10.1016/j.yexmp.2004.12.002. Epub 2005 Feb 9.
10
Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.微管对肝细胞中细胞角蛋白聚集体(马洛里小体)的形成是必需的:一项体外研究。
Exp Mol Pathol. 2003 Apr;74(2):173-9. doi: 10.1016/s0014-4800(03)00005-4.

引用本文的文献

1
Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma.揭示角蛋白 8/18 相关信号蛋白在肝癌发展中的作用。
Int J Mol Sci. 2021 Jun 15;22(12):6401. doi: 10.3390/ijms22126401.
2
The role of the ubiquitin proteasome pathway in keratin intermediate filament protein degradation.泛素蛋白酶体途径在角蛋白中间丝蛋白降解中的作用。
Proc Am Thorac Soc. 2010 Feb;7(1):71-6. doi: 10.1513/pats.200908-089JS.
3
A cell culture system for the induction of Mallory bodies: Mallory bodies and aggresomes represent different types of inclusion bodies.
一种用于诱导马洛里小体的细胞培养系统:马洛里小体和聚集体代表不同类型的包涵体。
Histochem Cell Biol. 2009 Sep;132(3):293-304. doi: 10.1007/s00418-009-0598-9. Epub 2009 Apr 18.
4
S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory.S-腺苷甲硫氨酸通过抑制表观遗传记忆来预防药物引发的小鼠中马洛里小体的形成。
Hepatology. 2008 Feb;47(2):613-24. doi: 10.1002/hep.22029.
5
Bile acid-induced Mallory body formation in drug-primed mouse liver.胆汁酸诱导药物预处理小鼠肝脏中马洛里小体的形成。
Am J Pathol. 2002 Dec;161(6):2019-26. doi: 10.1016/S0002-9440(10)64480-X.
6
Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model.在人类酒精性肝炎以及马洛里小体小鼠模型中,肝细胞角蛋白在多个位点发生过度磷酸化。
Am J Pathol. 2000 Jan;156(1):77-90. doi: 10.1016/S0002-9440(10)64708-6.